AllovirInc Earnings Estimate

ALVR
 Stock
  

USD 7.09  0.02  0.28%   

Many public companies, such as AllovirInc, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing AllovirInc's earnings estimates, investors can diagnose different trends across AllovirInc's analyst sentiment over time as well as compare current estimates against different timeframes.
AllovirInc is projected to generate -2.64 in earnings per share on the 31st of December 2021. AllovirInc earnings estimates module stress-tests analyst consensus about projected AllovirInc EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please continue to Trending Equities.
  

AllovirInc Earnings Estimation Breakdown

Calculation of earning per share of AllovirInc is based on official Zacks consensus of 3 analysts regarding AllovirInc future annual earnings. Given the historical accuracy of 56.9%, the future earnings per share of AllovirInc is estimated to be -2.64 with the lowest and highest values of -2.73 and -2.57, respectively. Please note that this consensus of annual earnings estimates for AllovirInc is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -2.92
-2.73
Lowest
Expected EPS -2.64
-2.57
Highest

AllovirInc Earnings Projection Consensus

Suppose the current estimates of AllovirInc's value are higher than the current market price of the AllovirInc stock. In this case, investors may conclude that AllovirInc is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and AllovirInc's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

3

56.9%

-2.924

-2.64

AllovirInc Earnings per Share Projection vs Actual

Actual Earning per Share of AllovirInc refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering AllovirInc predict the company's earnings will be in the future. The higher the earnings per share of AllovirInc, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

AllovirInc Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as AllovirInc, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of AllovirInc should always be considered in relation to other companies to make a more educated investment decision.

AllovirInc Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact AllovirInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-03
2022-09-30-0.53-0.50.03
2022-08-04
2022-06-30-0.73-0.690.04
2022-05-05
2022-03-31-0.8-0.690.1113 
2022-02-10
2021-12-31-0.81-0.92-0.1113 
2021-11-05
2021-09-30-0.55-0.72-0.1730 
2021-08-06
2021-06-30-0.49-0.6-0.1122 
2021-05-06
2021-03-31-0.4-0.5-0.125 
2021-02-11
2020-12-31-0.42-0.340.0819 
2020-11-10
2020-09-30-0.3-0.58-0.2893 
2020-07-30
2020-06-30-0.31-0.040.2787 
2020-06-03
2020-03-310-4.21-4.21

About AllovirInc Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of AllovirInc earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current AllovirInc estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as AllovirInc fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AllovirInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AllovirInc's short interest history, or implied volatility extrapolated from AllovirInc options trading.

Pair Trading with AllovirInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AllovirInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AllovirInc will appreciate offsetting losses from the drop in the long position's value.

Moving against AllovirInc

-0.56KOCoca-Cola Aggressive PushPairCorr
-0.54BMYBristol-Myers Squibb Aggressive PushPairCorr
-0.53MMM3M Company Sell-off TrendPairCorr
-0.52CAHCardinal Health Sell-off TrendPairCorr
The ability to find closely correlated positions to AllovirInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AllovirInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AllovirInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AllovirInc to buy it.
The correlation of AllovirInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AllovirInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AllovirInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AllovirInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
672.6 M
Return On Assets
(0.38) 
Return On Equity
(0.72) 
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.